Lilyana Amezcua, MD

Articles by Lilyana Amezcua, MD

From Guidelines to Practice: Challenges in Applying Updated MS Diagnostic Criteria

ByMarco Meglio,Adnan Subei, DO, FAAN,Lilyana Amezcua, MD,Samantha Roman, MD

March 30th 2026

A group of neuroimmunologists discuss how the updated McDonald criteria will shape neurologist training and highlight key barriers to implementation, including imaging access, resource limitations, and knowledge dissemination.

From Trial to Practice: How the 2024 Criteria Perform in Real-World Settings

ByMarco Meglio,Adnan Subei, DO, FAAN,Lilyana Amezcua, MD,Samantha Roman, MD

March 29th 2026

Panelists review emerging real-world and ECTRIMS data demonstrating that the updated McDonald criteria improve earlier MS diagnosis while maintaining diagnostic accuracy across diverse clinical settings.

Treating Before Symptoms: Managing RIS in the Era of Updated Multiple Sclerosis Criteria

ByMarco Meglio,Adnan Subei, DO, FAAN,Lilyana Amezcua, MD,Samantha Roman, MD

March 28th 2026

Experts discuss how the updated McDonald criteria redefine radiologically isolated syndrome and explore the clinical, imaging, and access challenges of diagnosing and treating MS before symptom onset.

Overviewing Key Updates in the 2024 McDonald Criteria for Multiple Sclerosis

ByMarco Meglio,Adnan Subei, DO, FAAN,Lilyana Amezcua, MD,Samantha Roman, MD

March 27th 2026

A panel of MS experts breaks down the most impactful updates to the 2024 McDonald criteria, highlighting how new biomarkers, imaging features, and diagnostic flexibility are reshaping earlier and more accurate MS diagnosis.